FIELD: organic chemistry, biochemistry, pharmacy.
SUBSTANCE: invention relates to new derivatives of β-carboline of the general formula (I) 
showing properties of phosphodiesterase V inhibitor (PDE V). In the general formula (I) R1 means hydrogen atom; n = 0; X is taken among the group consisting of oxygen (O), sulfur (S) atoms and NRD; R2 is taken among the following group: phenyl (that can be optionally substituted with 1-3 RB), 6-membered nitrogen-containing heteroaryl and 5-6-membered heterocycloalkyl comprising 1-2 oxygen atoms and condensed with benzene ring (optionally substituted with 1-3 RB); R4 is taken among the group consisting of hydrogen atom, carboxy-group. (C1-C6)-alkylcarbonyl, di-[C1-C8)-alkyl]-aminoalkoxycarbonyl, di-[(C1-C8)-alkyl]-amino-(C1-C8)-alkylaminocarbonyl; a = a whole number from 0 to 1; Y is taken among the group consisting of -CH2, -C(O); Z is taken among the group consisting of -CH2, -CHOH, and -C(O) under condition that when Z represents -CHOH or -C(O) then X represents -NH; 
is taken among the group consisting of naphthyl, 5-6-membered heteroaryl comprising 1-3 heteroatoms taken among nitrogen, oxygen and/or sulfur atoms possibly condensed with benzene ring; m = a whole number from 0 to 2; R3 is taken independently among the group consisting of halogen atom, nitro-group, (C1-C8)-alkyl, (C1-C8)-alkoxy-group, trifluorophenyl, phenyl (optionally substituted with 1-3 RB), phenylsulfonyl, naphthyl, (C1-C8)-aralkyl, 5-6-membered heteroaryl comprising 1-3 nitrogen atoms in the ring (optionally substituted with 1-3 RB). Also, invention relates to a pharmaceutical composition, a method for its preparing and methods for inhibition of phosphodiesterase V activity (PDE V), and for increase of the cGMP concentration.
EFFECT: improved preparing method, valuable medicinal and biochemical properties of compounds and composition.
14 cl, 11 sch, 7 tbl, 13 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF SUBSTITUTED PYRROLOPYRIDINONE USEFUL AS PHOSPHODIESTERASE INHIBITORS | 2001 |
|
RU2267490C2 |
| BETA-CARBOLINE COMPOUNDS, PHARMACEUTICAL COMPOSITIONS BASED ON THEREOF AND METHODS FOR BINDING, ATTAINMENT OF AGONISTIC/ANTAGONISTIC EFFECT | 1999 |
|
RU2233841C2 |
| USE OF INHIBITORS OF CGMP-PHOSPHODIESTERASE FOR TREATMENT OF IMPOTENCY | 1996 |
|
RU2181288C2 |
| DERIVATIVES OF β-CARBOLINE, METHODS FOR PREPARING AND MEDICINAL AGENT | 1999 |
|
RU2210571C2 |
| METHOD OF PRODUCTION OF 1- AND 1,1-DISUBSTITUTED-4-PHENYL-2,3,4,9-TETRAHYDRO-1H-BETA-CARBOLINE | 2004 |
|
RU2332418C2 |
| DERIVATIVES OF PYRIDAZINOQUINOLINE | 1994 |
|
RU2168511C2 |
| METHOD FOR TREATMENT OF ALLERGY BY USING SUBSTITUTED PYRAZOLES | 2001 |
|
RU2259202C2 |
| HETEROCYCLIC COMPOUNDS AS POSITIVE MODULATORS OF METABOTROPIC GLUTAMATE RECEPTOR 2 (MGLU2 RECEPTOR) | 2008 |
|
RU2479577C2 |
| SUBSTITUTED PYRAZOLES | 2001 |
|
RU2286343C2 |
| SUBSTITUTED PYRAZOLES, PHARMACEUTICAL COMPOSITION AND METHOD FOR INHIBITION OF CATHEPSIN S ACTIVITY | 2001 |
|
RU2278863C2 |
